Actively Recruiting
A Registered Cohort Study on Duchenne Muscular Dystrophy
Led by Ning Wang, MD., PhD. · Updated on 2021-03-22
2000
Participants Needed
1
Research Sites
1591 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Dystrophinopathy is a term of X-linked recessive genetic disease, including Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and the X-linked dilated cardiomyopathy. The aim of this study is to determine the clinical spectrum and natural progression of dystrophinopathy in a prospective multicenter natural history study, to assess the clinical, genetic of patients with dystrophinopathy to optimize clinical management.
CONDITIONS
Official Title
A Registered Cohort Study on Duchenne Muscular Dystrophy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant is older than 2 years
- Diagnosed with Duchenne Muscular Dystrophy or is a female carrier confirmed by genetic testing
- Diagnosis supported by muscle biopsy if no genetic confirmation is available
You will not qualify if you...
- Presence of other clinically significant illnesses
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
First Affiliated Hospital of Fujian Medical University
Fuzhou, China
Actively Recruiting
Research Team
N
Ning Wang, MD, PhD
CONTACT
M
Ming Jin, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here